Core--Pathology
Core--Pathology
批准号:
7009886
负责人:
Robert B Colvin
金额:
$15.61万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2010-06-30
关键词:
biomedical facilitycytokineelectron microscopyenzyme linked immunosorbent assayflow cytometryheart transplantationhistologyimmune tolerance /unresponsivenessimmunocytochemistryimmunofluorescence techniqueimmunopathologyimmunoperoxidaselaser capture microdissectionlung transplantationmolecular pathologymonoclonal antibodypathologypolymerase chain reactiontissue /cell culturetissue mosaicismtransplantation immunology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of the Pathology Core is to provide common facilities and expertise for the immunopathological studies in all three projects. The primary role of the pathological analyses in these allograft protocols is to document and characterize the status of the graft (nature of infiltrate, presence of acute or chronic rejection, including a humoral component) and the systemic effects of the protocols (toxicity, complications). In addition, the immunopathologic and molecular studies will give insights into the mechanisms of graft rejection and acceptance with protocol biopsies The techniques that will be utilized include routine histology, immunohistochemistry, immunofluorescence, electron microscopy, PCR, ELISPOT/cell culture, and flow cytometry. Immunoperoxidase techniques with a panel of mAbs will distinguish the infiltrating cell types, adhesion and cytokine molecules and receptors, and activation markers. Immunofluorescence will be used to localize the deposition of immunoglobulin and
complement, as well as double/triple staining for cell markers using digital imaging. C4d stains will be used to detect humoral rejection. RT-PCR will be used to detect and quantify synthesis of key cytokines. Laser capture microdissection will be used for some of these studies in most of the projects to select the appropriate cells. Markers of apoptosis/DNA fragmentation (TUNEL) will assess cell injury. Culture of graft cells will be used with ELISPOT to correlate with the functional studies in the blood. Chimerism will be detected by flow cytometry techniques. The protocols are given in detail in each of the individual Projects. The pathology features will be assessed and graded by the same group pathologists for all studies, which we consider an important asset of the Program Project. The panel of antibodies and cytokine probes will
also be comparable, whenever possible. This should promote cross-fertilization among the projects by extension of novel findings and provide insights into the general significance of the results in one project by comparing and contrasting grafts in different species and between different organs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunopathologic Studies
-
批准号:8432088
-
项目类别:
-
资助金额:$13.31万
-
财政年份:2012
-
负责人:Robert B Colvin
-
依托单位:
Immunopathologic Studies
-
批准号:8725788
-
项目类别:
-
资助金额:$14.29万
-
财政年份:2012
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:8071240
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:8260821
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Pathology
-
批准号:8134128
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:8462892
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:7985705
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Immunopathology
-
批准号:7680751
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2009
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of acceptance of mouse renal allografts
-
批准号:7848042
-
项目类别:
-
资助金额:$44.19万
-
财政年份:2009
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6580448
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2002
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6445528
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6302105
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2000
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6296843
-
项目类别:
-
资助金额:$38.26万
-
财政年份:1999
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6109465
-
项目类别:
-
资助金额:$38.26万
-
财政年份:1999
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6272551
-
项目类别:
-
资助金额:$34.2万
-
财政年份:1998
-
负责人:Robert B Colvin
-
依托单位:
IMMUNOLOGY AND TUMORS
-
批准号:2085079
-
项目类别:
-
资助金额:$16.46万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
IMMUNOLOGY AND TUMORS
-
批准号:3532786
-
项目类别:
-
资助金额:$6.49万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
IMMUNOLOGY AND TUMORS
-
批准号:3532788
-
项目类别:
-
资助金额:$15.72万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGY
-
批准号:2085080
-
项目类别:
-
资助金额:$17.77万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGY
-
批准号:2085081
-
项目类别:
-
资助金额:$12.88万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: